Norway· NO-ID_95CAFB63-A0C3-4707-9E5D-950415559848
Ansatipin
A rifabutin product containing rifabutin, registered in Norway by SERB. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Rifabutin is registered in 15 of 19 countries.
Countries holding a registration under ATC J04AB04 (rifabutin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Rifabutin · ATC J04AB04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of rifabutin costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Rifabutin · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.51
The record
At a glance
FEST (Norway)- Active substance
- Rifabutin
- Manufacturer
- SERB
- Country
- Norway (NO)
- ATC code
- J04AB04
- ATC class
- Rifabutin
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 2
- no_varenummer26771430
- no_merkevare_idID_95CAFB63-A0C3-4707-9E5D-950415559848
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
278 interactions on record for rifabutin.
Graded by severity as the source publishes them — 91 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rifabutin · interactions on record
278 records
- 91 severe
- 146 moderate
- 8 minor
Most severe, free to view
- RolapitantA04AD14severe
- EliglustatA16AX10severe
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rifabutin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRifabutinREMEDYREPACK INC.
- FinlandAnsatipinPfizer Oy
- United KingdomMycobutin 150mg capsulesPfizer Ltd
- SpainANSATIPIN 150 MG CÁPSULAS DURASBinesa 2002 S.L.
- BelgiumMycobutin 150 mgPfizer
- IrelandMycobutin 150mg Hard CapsulesPfizer Healthcare Ireland Unlimited Company
- NetherlandsMycobutin, capsules 150 mgPfizer B.V.
- SwedenAnsatipin 150 mg Kapsel, hårdPfizer AB
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Mycobutin
- Belgium · Mycobutin
- Czechia · Mycobutin
- Germany · Mycobutin
- Spain · Ansatipin
- Finland · Ansatipin
- France · Ansatipine
- United Kingdom (Northern Ireland) · Mycobutin, Rifabutin Pfizer
- Ireland · Mycobutin
- Italy · Mycobutin
- Luxembourg · Mycobutin
- Netherlands · Mycobutin
- Portugal · Mycobutin
- Sweden · Ansatipin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9640c34d-4bc3-4b38-b436-81fbd0c4f206 GET /v1/drugs/9640c34d-4bc3-4b38-b436-81fbd0c4f206?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Rifabutin",
"merkevare_id": "ID_95CAFB63-A0C3-4707-9E5D-950415559848",
"name_form_strength": "Ansatipin kaps 150 mg",
"prescription_group": "C"
}See everything about rifabutin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.